A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...
A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.
In a remarkable display of market confidence, HIMS & Hers Health, Inc. (HIMS) stock has soared to an all-time high, with shares hitting a peak of $46.11. This milestone underscores the company's ...